Brandywine Global Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $71.2M | Buy |
2,857,645
+1,250,255
| +78% | +$31.5M | 0.48% | 53 |
|
|
2025
Q3 | $41M | Sell |
1,607,390
-30,184
| -2% | -$745K | 0.28% | 104 |
|
|
2025
Q2 | $39.7M | Buy |
1,637,574
+503,895
| +44% | +$11.8M | 0.28% | 98 |
|
|
2025
Q1 | $28.7M | Sell |
1,133,679
-75,456
| -6% | -$1.97M | 0.21% | 130 |
|
|
2024
Q4 | $32.1M | Sell |
1,209,135
-7,064
| -0.6% | -$192K | 0.23% | 112 |
|
|
2024
Q3 | $35.4M | Sell |
1,216,199
-794
| -0.1% | -$23.2K | 0.24% | 106 |
|
|
2024
Q2 | $34.1M | Sell |
1,216,993
-48,741
| -4% | -$1.34M | 0.25% | 97 |
|
|
2024
Q1 | $35.1M | Sell |
1,265,734
-576,438
| -31% | -$16M | 0.25% | 101 |
|
|
2023
Q4 | $53M | Buy |
1,842,172
+95,220
| +5% | +$2.88M | 0.43% | 66 |
|
|
2023
Q3 | $57.9M | Sell |
1,746,952
-60,929
| -3% | -$2.15M | 0.51% | 53 |
|
|
2023
Q2 | $66.3M | Sell |
1,807,881
-3,224,121
| -64% | -$125M | 0.55% | 48 |
|
|
2023
Q1 | $205M | Buy |
5,032,002
+16,307
| +0.3% | +$704K | 1.66% | 3 |
|
|
2022
Q4 | $257M | Buy |
5,015,695
+774,656
| +18% | +$37.1M | 2.01% | 3 |
|
|
2022
Q3 | $186M | Sell |
4,241,039
-239,696
| -5% | -$11.6M | 1.73% | 4 |
|
|
2022
Q2 | $235M | Buy |
4,480,735
+3,214,678
| +254% | +$164M | 2.04% | 4 |
|
|
2022
Q1 | $65.5M | Buy |
1,266,057
+300,889
| +31% | +$15.6M | 0.48% | 51 |
|
|
2021
Q4 | $57M | Sell |
965,168
-485,966
| -33% | -$24.1M | 0.41% | 68 |
|
|
2021
Q3 | $62.4M | Buy |
1,451,134
+616,250
| +74% | +$27.3M | 0.47% | 53 |
|
|
2021
Q2 | $32.7M | Sell |
834,884
-11,624
| -1% | -$452K | 0.24% | 111 |
|
|
2021
Q1 | $30.7M | Sell |
846,508
-4,361,095
| -84% | -$155M | 0.23% | 118 |
|
|
2020
Q4 | $192M | Sell |
5,207,603
-392,491
| -7% | -$14.4M | 1.59% | 8 |
|
|
2020
Q3 | $195M | Sell |
5,600,094
-505,180
| -8% | -$17.7M | 1.92% | 7 |
|
|
2020
Q2 | $189M | Buy |
6,105,274
+1,911,845
| +46% | +$65M | 1.93% | 7 |
|
|
2020
Q1 | $130M | Sell |
4,193,429
-535,948
| -11% | -$18.3M | 1.55% | 12 |
|
|
2019
Q4 | $176M | Sell |
4,729,377
-1,183,278
| -20% | -$42.1M | 1.24% | 13 |
|
|
2019
Q3 | $202M | Sell |
5,912,655
-2,523,464
| -30% | -$91.8M | 1.48% | 11 |
|
|
2019
Q2 | $347M | Sell |
8,436,119
-337,970
| -4% | -$13.4M | 2.4% | 5 |
|
|
2019
Q1 | $354M | Buy |
8,774,089
+2,630,139
| +43% | +$105M | 2.44% | 3 |
|
|
2018
Q4 | $254M | Sell |
6,143,950
-876,725
| -12% | -$36.4M | 1.88% | 5 |
|
|
2018
Q3 | $294M | Sell |
7,020,675
-466,888
| -6% | -$18M | 1.83% | 6 |
|
|
2018
Q2 | $258M | Sell |
7,487,563
-851,054
| -10% | -$29.1M | 1.64% | 7 |
|
|
2018
Q1 | $281M | Buy |
8,338,617
+443,129
| +6% | +$15.2M | 1.77% | 6 |
|
|
2017
Q4 | $271M | Buy |
7,895,488
+829,282
| +12% | +$28.3M | 1.62% | 7 |
|
|
2017
Q3 | $239M | Sell |
7,066,206
-226,912
| -3% | -$7.29M | 1.52% | 10 |
|
|
2017
Q2 | $232M | Sell |
7,293,118
-171,136
| -2% | -$5.4M | 1.48% | 10 |
|
|
2017
Q1 | $242M | Buy |
7,464,254
+370,081
| +5% | +$11.7M | 1.53% | 9 |
|
|
2016
Q4 | $219M | Sell |
7,094,173
-86,917
| -1% | -$2.65M | 1.39% | 11 |
|
|
2016
Q3 | $231M | Sell |
7,181,090
-198,849
| -3% | -$6.65M | 1.52% | 9 |
|
|
2016
Q2 | $247M | Sell |
7,379,939
-265,205
| -3% | -$8.46M | 1.66% | 8 |
|
|
2016
Q1 | $215M | Buy |
7,645,144
+40,727
| +0.5% | +$1.16M | 1.4% | 11 |
|
|
2015
Q4 | $233M | Buy |
7,604,417
+623,930
| +9% | +$19.6M | 1.48% | 13 |
|
|
2015
Q3 | $208M | Sell |
6,980,487
-1,752,379
| -20% | -$56.2M | 1.36% | 14 |
|
|
2015
Q2 | $278M | Buy |
8,732,866
+550,833
| +7% | +$18M | 1.74% | 9 |
|
|
2015
Q1 | $270M | Buy |
8,182,033
+2,582,565
| +46% | +$82.1M | 1.74% | 9 |
|
|
2014
Q4 | $165M | Buy |
5,599,468
+1,512,764
| +37% | +$43.4M | 1.11% | 16 |
|
|
2014
Q3 | $115M | Sell |
4,086,704
-4,005,305
| -49% | -$112M | 0.84% | 26 |
|
|
2014
Q2 | $228M | Buy |
8,092,009
+708,915
| +10% | +$20.2M | 1.78% | 8 |
|
|
2014
Q1 | $225M | Buy |
7,383,094
+205,924
| +3% | +$6.14M | 1.95% | 7 |
|
|
2013
Q4 | $209M | Buy |
7,177,170
+20,488
| +0.3% | +$596K | 1.91% | 9 |
|
|
2013
Q3 | $195M | Buy |
7,156,682
+47,361
| +0.7% | +$1.29M | 1.94% | 5 |
|
|
2013
Q2 | $189M | Buy |
+7,109,321
| New | +$196M | 1.94% | 9 |
|
Other funds holding PFE
Brandywine Global Investment Management's PFE Position: Q4 2025 in Review
Brandywine Global Investment Management increased its Pfizer (PFE) stake by 78% in Q4 2025, buying an estimated $31.5M and bringing the position to 2,857,645 shares worth $71.2M. The position accounts for 0.48% of the portfolio, ranked #53.
Brandywine Global Investment Management first reported a position in PFE in Q2 2013 and has held it in 51 quarters since. The position peaked at $354M in Q1 2019. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Brandywine Global Investment Management held 2,857,645 shares of Pfizer worth $71.2M as of Q4 2025.
- Brandywine Global Investment Management bought 1,250,255 Pfizer shares in Q4 2025, an estimated $31.5M.
- Pfizer made up 0.48% of Brandywine Global Investment Management's portfolio in Q4 2025, its #53 holding.
- Brandywine Global Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 51 quarters since.
- Brandywine Global Investment Management's Pfizer position peaked at $354M in Q1 2019.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.